drugset
Drugs / SYN321
last change Apr 2026 re-read 3 minutes ago

SYN321

Developed for
osteoarthritis, knee

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy1 trial
Phase 1/2 NCT06989645 Comparator Aug 2025 → Feb 2026 osteoarthritis, knee Synartro AB Completed No outcome recorded

Press releases naming this drug 12 releases

DateIssuerRelease
2026-04-09 Synartro AB Synartro reports positive phase 1/2a data for SYN321 cision.com ↗
2026-02-18 Synartro AB Synartro reports last participant’s last visit (LPLV) in phase 1/2a clinical study of OA drug candidate SYN321 cision.com ↗
2026-01-09 Synartro AB No serious adverse events to date in ongoing phase 1/2a clinical study of SYN321 cision.com ↗
2025-12-15 Synartro AB Synartro – completed treatment of all four cohorts in phase 1/2a clinical study of SYN321 cision.com ↗
2025-10-21 Synartro AB Synartro - dosing of second cohort completed in clinical study of SYN321 cision.com ↗
2025-09-23 Synartro AB Synartro completes dosing of first cohort in clinical study of SYN321 cision.com ↗
2023-04-27 Synartro AB Synartro has been granted regulatory and ethical approval for the first clinical trial of lead compound SYN321 for treatment of symptomatic knee osteoarthritis cision.com ↗
2023-04-27 Synartro AB Synartro har erhållit regulatorisk och etiskt godkännande att starta första kliniska studien av sin substans SYN321 för behandling av symtomatisk knäartros cision.com ↗
2023-01-31 Synartro AB Synartro prepares for first clinical trial of lead compound SYN321 for treatment of symptomatic knee osteoarthritis cision.com ↗
2023-01-31 Synartro AB Synartro förbereder sig för den första kliniska studien av sin substans SYN321 för behandling av symtomatisk knäartros cision.com ↗
2021-10-05 Synartro AB Goda inledande resultat i Synartros prekliniska utveckling av SYN321 cision.com ↗
2020-12-22 Synartro AB Synartro rapporterar positivt utfall från effektstudie av SYN321 cision.com ↗

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as SYN321 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06989645 ↗